ZVRA Q1 2021 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+480.0% YoY

Gross Profit

$11M91.7% margin

Operating Income

$7M57.4% margin

Net Income

-$10M-85.0% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

+412.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$675,000

Balance Sheet

Total Assets

$90M

Total Liabilities

$6M

Stockholders' Equity

$84M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$2M	+480.0%
Gross Profit	$11M	$1M	+679.6%
Operating Income	$7M	-$4M	+284.4%
Net Income	-$10M	-$6M	-78.9%